E I Chazov Selected Research

E I Chazov Research Topics

Disease

6	Atrial Fibrillation 10/2017 - 01/2004
4	Myocardial Infarction 09/2019 - 07/2002
4	Ischemia 01/2013 - 09/2001
3	Inflammation (Inflammations) 10/2011 - 09/2005
2	Neoplasms (Cancer) 09/2019 - 03/2011
2	Hypertension (High Blood Pressure) 01/2014 - 01/2000
2	Body Weight (Weight, Body) 01/2014 - 03/2011
2	Infarction (Infarctions) 01/2013 - 01/2012
2	Stable Angina 10/2011 - 01/2005
2	Hypoxia (Hypoxemia) 05/2007 - 01/2005
2	Cardiovascular Diseases (Cardiovascular Disease) 05/2007 - 01/2002
2	Heart Failure 05/2005 - 01/2005
1	Neoplasm Metastasis (Metastasis) 09/2019
1	Thrombosis (Thrombus) 09/2019
1	Morbid Obesity 10/2017
1	Obesity 10/2017
1	Atrial Flutter (Flutter, Atrial) 01/2015
1	Torsades de Pointes (Torsade de Pointes) 01/2014
1	Hypertensive Crisis 01/2014
1	Ventricular Tachycardia 01/2014
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2013
1	Reperfusion Injury 01/2012
1	Supraventricular Tachycardia 01/2012
1	Vascular Remodeling 05/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2007
1	Essential Hypertension 05/2007
1	Pain (Aches) 01/2005
1	Coronary Restenosis 10/2001
1	Neointima 05/2001
1	Pathologic Constriction (Stenosis) 05/2001
1	Acute Coronary Syndrome 01/2000

Drug/Important Bio-Agent (IBA)

4	niferidilIBA 01/2015 - 01/2011
3	Peptides (Polypeptides)IBA 01/2013 - 09/2005
3	Oxygen (Dioxygen)IBA 05/2007 - 01/2005
2	Proteins (Proteins, Gene)FDA Link 09/2019 - 09/2005
2	Anti-Arrhythmia AgentsIBA 10/2017 - 01/2004
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 05/2005
2	LigandsIBA 03/2011 - 05/2005
2	A-factor (Streptomyces)IBA 01/2006 - 01/2005
1	Fibrinolysin FDA Link 09/2019
1	PotassiumIBA 01/2015
1	Antihypertensive Agents (Antihypertensives)IBA 01/2014
1	Nitric Oxide DonorsIBA 01/2014
1	dinitrosyl iron complexIBA 01/2014
1	arginylprolineIBA 01/2013
1	apelin-12 peptideIBA 01/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2013
1	lysylglycineIBA 01/2013
1	seryl-histidineIBA 01/2013
1	AntioxidantsIBA 01/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	EnzymesIBA 01/2013
1	hydroxide ionIBA 01/2013
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2013
1	compound A 12 (A-12)IBA 01/2012
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2012
1	ApelinIBA 01/2012
1	Heparin (Liquaemin)FDA LinkGeneric 10/2011
1	ingramonIBA 10/2011
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2011
1	Peptide FragmentsIBA 10/2011
1	SolutionsIBA 03/2011
1	Sulfhydryl Compounds (Thiols)IBA 03/2011
1	Cysteine (L-Cysteine)FDA Link 01/2008
1	IronIBA 01/2008
1	CholesterolIBA 05/2007
1	Triglycerides (Triacylglycerol)IBA 05/2007
1	nibentan (HE 11)IBA 01/2007
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2007
1	C-Reactive ProteinIBA 01/2006
1	Interleukin-6 (Interleukin 6)IBA 01/2006
1	GlobinsIBA 05/2005
1	Trimetazidine (Vastarel)IBA 01/2005
1	W 12IBA 01/2005
1	NitratesIBA 01/2005
1	Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric 07/2002
1	IntegrinsIBA 10/2001
1	Hydroxyl RadicalIBA 09/2001
1	Poloxamer (Poloxamer 407)IBA 05/2001
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2001
1	Plasminogen Activators (Plasminogen Activator)IBA 05/2001
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2001
1	Hormones (Hormone)IBA 01/2000

Therapy/Procedure

5	Electric Countershock (Cardioversion) 10/2017 - 01/2007
2	Therapeutics 01/2005 - 01/2000
1	Intravenous Administration 01/2013
1	Intravenous Infusions 03/2011
1	Secondary Prevention 01/2002
1	Catheters 05/2001